Arvinas to Participate in Upcoming Investor Conferences

NEW HAVEN, Conn., June 03, 2024 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will...

Related Keywords

Miami ,Florida ,United States ,New York ,Kathleen Murphy ,Noah Berkowitz ,John Houston ,Jeff Boyle ,Goldman Sachs ,Novartis ,Arvinas Inc ,Nasdaq ,Global Healthcare Conference ,Chief Executive Officer ,Chief Medical Officer ,Annual Global Healthcare Conference ,Discovery Engine ,Hodgkin Lymphoma ,